How are atrial septal defects (ASDs) classified by size in pediatric (peds) patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atrial Septal Defect Size Classification in Pediatric Patients

Atrial septal defects (ASDs) in pediatric patients are primarily classified as small (≤2.0 cm) or moderate to large (>2.0 cm), with this classification based on hemodynamic significance rather than absolute measurements alone. 1

Standard Classification System

According to the American College of Cardiology/American Heart Association/American Society of Echocardiography guidelines, ASDs are classified as:

  • Small: ASDs that are likely to be hemodynamically insignificant
  • Moderate to large: ASDs that are likely to be hemodynamically significant
  • Present, but unable to characterize further: When size cannot be adequately determined 1

Size-Specific Criteria

The European Society of Cardiology provides more specific size measurements:

  • Small to moderate: ≤2.0 cm in diameter
  • Large: >2.0 cm in diameter 1, 2

For infants and younger children, some studies use more age-appropriate size classifications:

  • In infants:

    • Small: ≤5 mm
    • Medium: 6-9 mm
    • Large: >9 mm 3
  • In children and adolescents:

    • Small: ≤10 mm
    • Medium: 10-20 mm
    • Large: >20 mm 3

Clinical Significance of Size Classification

The size classification directly correlates with clinical outcomes and management decisions:

  • Small defects (<6 mm): High likelihood of spontaneous closure (79-89%) 4, 3
  • Medium defects (6-9 mm): May regress in size but have lower spontaneous closure rates
  • Large defects (>8-10 mm): Rarely close spontaneously and typically require intervention 4, 3

Hemodynamic Impact

The classification system prioritizes hemodynamic significance over absolute size:

  • Hemodynamically insignificant (small): Minimal right heart volume overload, no pulmonary hypertension
  • Hemodynamically significant (moderate to large): Right heart enlargement, increased pulmonary blood flow, risk of pulmonary hypertension 1, 2

Risk Stratification

The size classification helps predict complications:

  • Small defects: Only 3% develop pulmonary hypertension
  • Large defects: Up to 50% develop pulmonary arterial hypertension with pulmonary vascular disease 1, 2

Management Implications

The size classification directly guides treatment decisions:

  • Small ASDs (<6 mm): Often managed conservatively with monitoring for spontaneous closure
  • Medium ASDs (6-10 mm): May require closure if no regression is observed
  • Large ASDs (>10 mm): Usually require surgical or transcatheter closure 2, 3

Measurement Technique

Accurate measurement is crucial and typically performed using:

  • Transthoracic echocardiography from subxyphoid long and short axis views
  • Transesophageal echocardiography when better visualization is needed 4, 5

The classification of ASDs by size in pediatric patients is essential for predicting clinical outcomes and determining appropriate management strategies, with the primary distinction being between hemodynamically significant and insignificant defects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Atrial Septal Defects Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Clinical Course of Patients With Atrial Septal Defects.

Iranian journal of pediatrics, 2016

Research

Spontaneous closure of atrial septal defects.

Pediatric cardiology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.